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Background: A history of congestive heart failure has been used to determine the prognosis in patients with acute
pulmonary embolism. Diastolic dysfunction is responsible for the half of congestive heart failure but has not been
understood well.
Methods: A total of 205 patients were reported admitted with acute pulmonary embolism from January 2009 to
July 2011. We excluded hemodynamically unstable patients who received thrombolytics or underwent
thromboembolectomy. We included hemodynamically stable patients who underwent echocardiogram
within 72 hours of diagnosis. We reviewed medical records of 107 patients to investigate whether diastolic
dysfunction increases in-hospital mortality or adverse clinical outcomes.
Results: Out of 107 patients, 10 patients died during hospitalization with in-hospital mortality rate of 9.3%. Among 84
patients without diastolic dysfunction as assessed by echocardiogram, six patients died with in-hospital mortality rate
of 7.1%. Meanwhile, among 23 patients with diastolic dysfunction, four patients died with in-hospital mortality rate of
17.4%. The multivariable adjusted odds ratio was calculated as 2.71, with 95% confidence interval of 0.59 - 12.44.
Conclusions: For hemodynamically stable patients with acute pulmonary embolism, diastolic dysfunction as assessed
by echocardiogram could increase in-hospital mortality 2.71 fold, although this was not statistically significant. Further
study with a large patient population is needed to determine the statistically significant implications of diastolic
dysfunction in patients with acute pulmonary embolism.
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Acute pulmonary embolism (PE) is a potentially life-
threatening condition. Hemodynamically stable patients
can be managed with anticoagulation alone, while
hemodynamically unstable patients need thrombolytics
or thromboembolectomy. Untreated patients can have
a mortality rate of 30%, whereas treatment can lower
the mortality rate down to 8% [1]. History of congestive
heart failure (CHF) has been regarded as a negative
prognostic factor according to the Pulmonary Embolism
Severity Index (PESI) [2,3].
CHF is a clinically diagnosed entity with characteristic
symptoms and physical findings. Patients who have systolic* Correspondence: choj2@ccf.org
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symptoms and signs, have preclinical systolic or diastolic
dysfunction. Unlike systolic dysfunction, diastolic dysfunc-
tion has not been understood well although this comprises
40 to 71% of CHF [4,5]. While we know that CHF can be
a negative prognostic factor in patients with acute PE, the
implications of diastolic dysfunction on patients with acute
PE have not been studied before. We investigate whether
diastolic dysfunction as assessed by echocardiogram can
be used as a prognostic factor in hemodynamically stable
patients with acute PE.Methods
Study population
We targeted hemodynamically stable patients with acute
PE. A total of 205 patients were reported admitted with
acute PE between January 2009 and July 2011. Our. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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who received thrombolytics or underwent thromboembo-
lectomy. Our eligibility criteria were hemodynamically
stable patients with systolic blood pressure of more than
90 mmHg who underwent echocardiogram within 72 hours
of diagnosis. Out of 205 patients, 107 patients were selected
meeting these criteria for our retrospective study (Figure 1).
We reviewed medical records to investigate whether dia-
stolic dysfunction as assessed by echocardiogram increases
in-hospital mortality or adverse clinical outcomes such as
shock, need for vasopressor, intubation or cardiopulmonary
resuscitation in patients with acute PE. All of these 107
patients were managed with intravenous heparin infusion
or subcutaneous enoxaparin.
Diagnosis of pulmonary embolism
Patients were diagnosed with acute PE with either com-
puted tomography or ventilation/perfusion lung scan.
Out of 107 patients, 100 patients (93.5%) were diagnosed
with computed tomography while 7 patients (6.5%) were
diagnosed with ventilation/perfusion lung scan.
Echocardiogram
We only included patients with acute PE who had echo-
cardiogram within 72 hours of diagnosis. Diagnosis of
diastolic dysfunction was made with the following char-
acteristics: mild (impaired relaxation without increased
filling pressure), moderate (impaired relaxation with
moderate elevation of filling pressure or pseudo-normal
filling pressure) and severe (advanced reduction in com-
pliance or reversible or fixed restrictive filling). E/A, E/e’
and deceleration time were used to classify diastolic dys-
function as mild, moderate and severe (E: peak early filling
velocity, A: velocity at atrial contraction, e’: velocity of mitral
annulus early diastolic motion). Normal diastolic function
was defined as 0.75 < E/A < 1.5, deceleration time > 140 ms
and E/e’ < 10; mild diastolic dysfunction was character-
ized with E/A < 0.75 and E/e’ < 10; moderate diastolic205 Patients 
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Figure 1 Patient selection.dysfunction was described as 0.75 < E/A < 1.5, deceleration
time > 140 ms and E/e’ > 10; severe diastolic dysfunction
was defined as E/A > 1.5, deceleration time < 140 ms and
E/e’ > 10 [6]. For patients with atrial fibrillation, E/e’ and
deceleration time were used to classify diastolic dysfunc-
tion since E/A could not be measured [7-9].
Study outcome
The primary study outcome was in-hospital death and
secondary study outcomes were adverse clinical events
such as shock, need for vasopressor, intubation and car-
diopulmonary resuscitation. Since we already excluded
hemodynamically unstable patients, the adverse clinical
outcomes of shock or need for vasopressor indicate in-
hospital adverse outcomes.
Statistical analysis
We used SPSS 19 for the statistical analysis. Differences
in baseline patient characteristics were compared using
the independent samples T-test for continuous variables
and chi-square test for categorical variables. Unadjusted
and multivariable adjusted odds ratio and P value were
calculated using binary logistic regression.
Institutional review board
This study was approved by the Institutional Review Board
at the University of Illinois at Urbana-Champaign, # 11095.
There was no ethical issue in our study since this is a retro-
spective medical record review.
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dysfunction (84 patients, 78.5%)
Patients with diastolic
dysfunction (23 patients, 21.5%)
P value
Age 58.1 ± 18.6 67.0 ± 17.0 0.040*
Male sex 43 (51.2%) 13 (56.5%) 0.650
Hypertension 49 (58.3%) 20 (86.9%) 0.011*
Diabetes mellitus 24 (28.6%) 7 (30.4%) 0.861
Hyperlipidemia 39 (46.4%) 10 (43.5%) 0.801
CAD 23 (27.4%) 5 (21.7) 0.623
COPD 13 (15.5%) 2 (8.7%) 0.407
CKD 6 (9.5%) 2 (8.7%) 0.802
CHF 8 (9.5%) 4 (17.4%) 0.289
Ejection fraction 59.1 ± 11.1 57.4 ± 8.0 0.491
Atrial fibrillation 15 (17.9%) 3 (13.0%) 0.585
Peripheral vascular disease 5 (6.0%) 3 (13.0%) 0.252
*indicates statistically significant result of P value < 0.05.
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thrombolytics or underwent thromboembolectomy and
patients who did not undergo echocardiogram within
72 hours of diagnosis, 107 patients were selected for our
retrospective study (Figure 1). Most of the baseline char-
acteristics were not statistically different between the two
groups except for age and hypertension (Table 1). Patients
with diastolic dysfunction were significantly older than
patients without diastolic dysfunction (67.0 ± 17.0 vs.
58.1 ± 18.6, P value 0.040). Patients with diastolic dys-
function had baseline hypertension significantly more
than patients without diastolic dysfunction (86.9% vs.
58.3%, P value 0.011). Of note, there was no difference in
EF between the two groups (59.1 vs. 57.4%, P value 0.491).
History of congestive heart failure
The history of CHF was obtained from medical records
when the patient has clinically diagnosed CHF before
developing acute PE. Eight patients had a diagnosis of
CHF before developing PE among 84 patients without
diastolic dysfunction (9.5%), and four patients had a
diagnosis among 23 patients with diastolic dysfunction
(17.4%). Most of the patients had systolic CHF except
for one patient who had documented diastolic CHF.
Diastolic dysfunction on echocardiogram
The prevalence of diastolic dysfunction on echocardiogram
in 107 patients with acute PE was 21.5% (23 patients out of
107 patients). We looked at previous echocardiogram toTable 2 In-hospital mortality (degree of diastolic dysfunction
Patients without diastolic
dysfunction (84, 78.5%) Mild (1
In-hospital death 6 (7.1%) 2 (find out the acuity of diastolic dysfunction but the data
were limited. The degree of diastolic dysfunction was mild
for 12 patients, moderate for 10 patients and severe for 1
patient (Table 2).
In-hospital mortality
The primary study outcome was in-hospital death. Out
of 107 patients, 10 patients died during hospitalization
with in-hospital mortality rate of 9.3%. The cause of death
for these 10 patients was pulmonary embolism. Among 84
patients without diastolic dysfunction as assessed by echo-
cardiogram, six patients died with in-hospital mortality
rate of 7.1%. Meanwhile, among 23 patients with diastolic
dysfunction as assessed by echocardiogram, four patients
died with in-hospital mortality rate of 17.4%. Based on
degree of diastolic dysfunction, in-hospital mortality was
calculated as 16.7% for mild diastolic dysfunction, 20% for
moderate diastolic dysfunction and 0% for severe diastolic
dysfunction (Table 2). The unadjusted odds ratio for
diastolic dysfunction was calculated as 2.74 with 95%
confidence interval of 0.70 - 10.67 (Table 3). The adjusted
odds ratio for age and hypertension was calculated as 2.71
with 95% confidence interval of 0.59 - 12.44 (Table 3).
Adverse clinical outcomes
We also looked at adverse clinical events as the secondary
outcomes. Adverse clinical outcomes included shock, need
for vasopressor, intubation and cardiopulmonary resuscita-
tion during hospitalization. The complications of shock and)
Patients with diastolic dysfunction (23, 21.5%)
2, 11.2%) Moderate (10, 9.3%) Severe (1, 1.0%)
16.7%) 2 (20%) 0 (0%)









In-hospital death 6 (7.1%) 4 (18.2%) 2.74 (0.70 – 10.67) 2.71 (0.59 – 12.44)
*Adjusted for age and hypertension.
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without diastolic dysfunction although these were not sta-
tistically significant (odds ratio for shock 0.21 with 95%
confidence interval of 0.03 - 1.67 and 0% vs. 6% for need
for vasopressor) (Table 4). There was no difference for
need for intubation between two groups (odds ratio 1.24
with 95% confidence interval 0.23 - 6.59). The need for
cardiopulmonary resuscitation was observed in 4.8% (pa-
tients without diastolic dysfunction) vs. 0% (patients with
diastolic dysfunction).
Discussion
A history of CHF is regarded as one of negative prog-
nostic factors in patients with acute PE. Although dia-
stolic dysfunction comprises significant portion of CHF,
the implications of diastolic dysfunction for predicting
mortality in patients with acute PE has not been investi-
gated before. We investigated whether diastolic dysfunc-
tion increases in-hospital mortality or adverse clinical
outcomes in patients with acute PE. Our study showed
that, for hemodynamically stable patients with acute PE,
diastolic dysfunction as assessed by echocardiogram
could increase in-hospital mortality 2.71 fold, although
this was not statistically significant.
Since we do not have baseline echocardiography for
most of the patients, we cannot determine whether this
is a chronic manifestation due to preclinical CHF or an
acute finding due to PE. There were several studies in
the past which investigated abnormal left ventricular dia-
stolic function in patients with chronic thromboembolic
hypertension, which revealed that the low left ventricular
preload and relative under-filling can cause diastolic dys-
function in patients with chronic PE [10,11]. So it is pos-
sible that acute PE can cause diastolic dysfunction by the
low preload and under-filling of the left ventricle. Based
on a previous study of Olmsted County, the prevalence
of diastolic dysfunction was reported as 20.8% for mild







N/A: Non-Available.for severe dysfunction [6]. Our study showed the preva-
lence of diastolic dysfunction in patients with acute PE of
21.5%, which supports the likelihood that diastolic dysfunc-
tion was more likely a chronic condition. Nonetheless, we
can safely say that patients with diastolic dysfunction on
echocardiogram have an increased mortality compared to
patients without diastolic dysfunction.
As shown in Table 3, adverse clinical outcomes varied.
The incidence of shock and need for vasopressor were
low in patient with diastolic dysfunction compared to
patients without diastolic dysfunction. Patients with dia-
stolic dysfunction were found to be more hypertensive
than patients without diastolic dysfunction as shown in
Table 1. This is probably the reason for the low rate of
shock and need for vasopressor in patients with diastolic
dysfunction. There was no difference in terms of need
for intubation or cardiopulmonary resuscitation between
the two groups. Unfortunately all the results were not
statistically significant and probably this is because of
low number of patients included in this analysis.
There are a few limitations in our retrospective study.
First of all, the increase of the mortality by 2.71 times is
not statistically significant. Although 7.1% vs. 17.4% could
be a striking difference, because of the small number of
patients included, we could not show a statistically signifi-
cant result. Further study with a large patient population
is needed to determine the statistically significant dif-
ference. Second, there were two differences in baseline
patient characteristics; age and hypertension. Both of
them are regarded as risk factors for diastolic dysfunction.
We already know that age is a negative prognostic factor
in patients with acute PE and diastolic dysfunction could
be dependent on old age. Third, we only included
hemodynamically stable patients with systolic blood
pressure more than 90 mmHg. We did not investigate
hemodynamically unstable patients who received throm-
bolytics or underwent thromboembolectomy. It could be




1 (4.3%) 0.21 (0.03 – 1.67)
0 (0%) N/A
2 (8.7%) 1.24 (0.23 – 6.59)
0 (0%) N/A
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our study when they got benefit from thrombolytics or
thromboembolectomy. This remains a future research
area.
Our research was a retrospective study of hemo-
dynamically stable patients with acute PE to see whether
diastolic dysfunction predicts increased in-hospital mor-
tality or adverse clinical outcomes. Even though this is a
retrospective study involving a small number of patients,
we reached an important finding. Further study is needed
with a large number of patients to reach a statistically sig-
nificant result and to investigate the benefit of thrombo-
lytics in patients with diastolic dysfunction.Conclusions
For hemodynamically stable patients with acute pulmonary
embolism, diastolic dysfunction as assessed by echocardio-
gram could increase in-hospital mortality 2.71 fold, al-
though this was not statistically significant. Further study
with a large patient population is needed to determine the
statistically significant implications of diastolic dysfunction
in patients with acute pulmonary embolism.
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